Literature DB >> 26050241

Severe opioid withdrawal syndrome after a single dose of nalmefene.

Nadine Donnerstag1, Tobias Schneider, Adrian Lüthi, Anne Taegtmeyer, Alexandra Raetz Bravo, Annekathrin Mehlig.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26050241     DOI: 10.1007/s00228-015-1884-1

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


× No keyword cloud information.
  4 in total

1.  Nalmefene: blockade of intravenous morphine challenge effects in opioid abusing humans.

Authors:  H E Jones; R E Johnson; P J Fudala; J E Henningfield; S J Heishman
Journal:  Drug Alcohol Depend       Date:  2000-07-01       Impact factor: 4.492

2.  Prolonged central mu-opioid receptor occupancy after single and repeated nalmefene dosing.

Authors:  Kimmo Ingman; Nora Hagelberg; Sargo Aalto; Kjell Någren; Auni Juhakoski; Sakari Karhuvaara; Antero Kallio; Vesa Oikonen; Jarmo Hietala; Harry Scheinin
Journal:  Neuropsychopharmacology       Date:  2005-12       Impact factor: 7.853

Review 3.  Nalmefene: a long-acting opioid antagonist. Clinical applications in emergency medicine.

Authors:  D S Wang; G Sternbach; J Varon
Journal:  J Emerg Med       Date:  1998 May-Jun       Impact factor: 1.484

Review 4.  Nalmefene: a new approach to the treatment of alcohol dependence.

Authors:  François Paille; Hervé Martini
Journal:  Subst Abuse Rehabil       Date:  2014-08-08
  4 in total
  2 in total

1.  Withdrawal syndrome after co-medication of opioid maintenance therapy with nalmefene: unrecognized interaction.

Authors:  Caroline Diot; Céline Eiden; Anne Roussin; Anne Batisse; Alexandra Boucher; François Chavant; Amélie Daveluy; Hélène Donadieu-Rigole; Hélène Peyrière
Journal:  Eur J Clin Pharmacol       Date:  2015-09-02       Impact factor: 2.953

Review 2.  Potential uses of naltrexone in emergency department patients with opioid use disorder.

Authors:  Evan Stuart Bradley; David Liss; Stephanie Pepper Carreiro; David Eric Brush; Kavita Babu
Journal:  Clin Toxicol (Phila)       Date:  2019-03-04       Impact factor: 4.467

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.